Envista Holdings Corp
NYSE:NVST
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.76
25.24
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
E
|
Envista Holdings Corp
NYSE:NVST
|
4B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
188.3B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.1B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
138.8B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
128.9B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.2B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.5B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.6B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Envista Holdings Corp
Glance View
Envista Holdings Corp., a prominent player in the dental industry, spins a captivating narrative of innovation and expertise. Emerging from a legacy rooted in the exceptional engineering standards of Danaher Corporation, Envista was formed to focus sharply on dental products and solutions. Its operational structure is divided into three main segments: Specialty Products & Technologies, Orthodontic Products, and Equipment & Consumables. With a strategic emphasis on orthodontics and endodontics, the company engineers advanced technological solutions such as clear aligners, imaging software, and digital treatment planning tools. This specialization is key to its operations, allowing Envista to cater to dental practitioners' diverse needs with products that boost the efficiency and precision of dental treatments. Revenue generation for Envista hinges upon its broad portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, which are synonymous with quality in the dental field. Through these brands, Envista not only manufactures and sells premium dental equipment and supplies, but also provides comprehensive services from maintenance and repair to educational support. The company utilizes a robust distribution network and partners with dental service organizations globally, ensuring its products reach a wide audience. Furthermore, Envista’s commitment to research and development fuels its profitability by continually offering state-of-the-art solutions that meet the evolving demands of the dental industry. This relentless focus on innovation and customer-centric approaches underpin its financial performance, positioning Envista as a formidable force in its market.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Envista Holdings Corp is 8.6%, which is below its 3-year median of 10.3%.
Over the last 3 years, Envista Holdings Corp’s Operating Margin has decreased from 14.6% to 8.6%. During this period, it reached a low of 6% on Mar 28, 2025 and a high of 14.6% on Sep 30, 2022.